title: Anaphylaxis: past, present and future.
abstract: Anaphylaxis is a clinical emergency, and recent reports suggest increased prevalence. A diverse set of primary genetic and environmental influences may confer susceptibility to anaphylactic reactions. Anaphylaxis presents diagnostic and therapeutic challenges. It often manifests with a broad array of symptoms and signs that might be similar to other diseases. The management of anaphylaxis consists of emergency treatment of acute episodes as well as preventive strategies to avoid recurrences. Treatment is complicated by its rapid onset and progression, presence of concurrent diseases or medications, and need for long-term allergen avoidance. Health care professionals must be able to recognize the signs of anaphylaxis, treat an episode promptly and appropriately, and provide preventive recommendations. Recognizing the gaps in our understanding and management of anaphylaxis may help identify promising targets for future treatment and prevention and areas that require further study.
authors.affiliation: Division of Pediatric Allergy and Clinical Immunology, Department of Pediatrics, McGill University Health Center, Montreal, QC, Canada. daliamoshebs@gmail.com
authors.forename: M
authors.initials: M
authors.lastname: Ben-Shoshan
authors.forename: A E
authors.initials: AE
authors.lastname: Clarke
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000485:Allergens / Q000009:adverse effects / Q000276:immunology; D000707:Anaphylaxis / Q000188:drug therapy / Q000453:epidemiology / Q000235:genetics / Q000503:physiopathology; D002648:Child; D004837:Epinephrine / Q000627:therapeutic use*; D020022:Genetic Predisposition to Disease; D006801:Humans; D008875:Middle Aged; D015995:Prevalence; D012106:Research / Q000639:trends; D012307:Risk Factors; D055815:Young Adult
chemical_list: D000485:Allergens; D004837:Epinephrine